CGTLive’s Weekly Rewind – September 15, 2023


Review top news and interview highlights from the week ending September 15, 2023.

Welcome to CGTLive™’s Weekly Rewind! We’ve compiled 5 highlights from this week’s coverage of advances in gene and cell therapies, including FDA actions, notable research, and interviews with experts across the field.

1. First Patient Receives Gene Therapy for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer

Adstiladrin was approved in December 2022 and is now available for select patients under an Early Experience Program.

2. Sharon Hesterlee, PhD, on Unprecedented Progress in Muscular Dystrophies

The chief research officer, Muscular Dystrophy Association, shared a message for Duchenne Action Month.

3. Novartis Drops Development of Geographic Atrophy Gene Therapy GT005

Novartis stated that the decision was made in light of a recommendation from an independent data monitoring committee.

4. Juan Francisco Cabello, MD, on the History and Current State of Newborn Screening

The head of the Pediatric Neurology Fellowship Program at the University of Valparaíso in Chile discussed positive impact of newborn screening so far and work that still needs to be done.

5. BioCardia Likely to Miss the Mark in Phase 3 CardiAMP Heart Failure Cell Therapy Trial

The company also announced its plans for a modified study protocol that may allow a roadway to approval.

Related Videos
Erika Fullwood Augustine, MD, MS, the associate chief science officer of the Kennedy Krieger Institute
Maria Escolar, MD, the chief medical officer of Forge Biologics
Casey Maguire, PhD, associate professor of neurology and associate investigator of neurology, Harvard Medical School
Evan Weber, PhD, an assistant professor of pediatrics at Children's Hospital of Philadelphia
Shankar Ramaswamy, MD, the cofounder, chairman, and CEO of Kriya Therapeutics
Kevin Campbell, PhD, a Howard Hughes Investigator at the University of Iowa
Debora Mazzetti, MS, on Multitargeting MicroRNA in Glioblastoma
Francesca Del Bufalo, MD, PhD, a medical doctor and scientist at Bambino Gesù Chidren’s Hospital
Travis Drow, BS, a research scientist at Seattle Children's Research Institute
Carlos Ramos, MD, on Alternatives to T-Cell Therapy
© 2024 MJH Life Sciences

All rights reserved.